Dr Stephen Berryman

A diagnostic test that can detect whether an animal has been infected by or vaccinated against any type of foot-and-mouth disease virus (FMDV) has been developed by scientists at The Pirbright Institute and Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER). The…

A novel foot-and-mouth disease (FMD) diagnostic reagent has been developed by scientists at The Pirbright Institute. This has the potential to be used in FMD diagnostic tests, and will be significantly quicker to produce when compared to existing test reagents due to a simplified production…

Dr Stephen Berryman and Dr Toby Tuthill from The Pirbright Institute have collaborated with the MRC Laboratory of Molecular Biology and other research institutes* to uncover a new system used by the foot-and-mouth disease virus (FMDV) to prevent antiviral signalling of infected cells. The discovery…

Researchers at The Pirbright Institute have shown that when drugs are used to inhibit the cellular protein, hsp90, foot-and-mouth disease virus (FMDV) production is reduced. Hsp90 is a protein used by cells to fold other proteins correctly and it was shown to be required by FMDV to form the outer…

Scientists at The Pirbright Institute, led by Gareth Shimmon, have found a new way of diagnosing foot-and-mouth disease (FMD) which is more cost effective and relies less on the use of small animals. FMD is a highly contagious viral disease that infects cloven-hoofed (two-toed) mammals such as…